{
    "N/R/U": null,
    "Applicant": "Emergent BioSolutions Canada Inc.",
    "BLA Number": "125462",
    "Proprietary Name": "Bat",
    "Proper Name": "Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G) - (Equine)",
    "BLA Type": "351(a)",
    "Strength": ">4500U",
    "Dosage Form": "Solution",
    "Route of Administration": "Intravenous",
    "Product Presentation": "Single-Dose Vial",
    "Marketing Status": "Rx",
    "Licensure": "Licensed",
    "Approval Date": "March 22, 2013",
    "Ref. Product Proper Name": " ",
    "Ref. Product Proprietary Name": null,
    "Supplement Number": "0",
    "Submission Type": "Original",
    "License Number": "2084",
    "Product Number": "001",
    "Center": "CBER",
    "Date of First Licensure": null,
    "Exclusivity Expiration Date": null,
    "First Interchangeable Exclusivity Exp. Date": null,
    "Ref. Product Exclusivity Exp. Date": null,
    "Orphan Exclusivity Exp. Date": "March 22, 2020"
}